deltatrials
Terminated PHASE1 INTERVENTIONAL 1-arm NCT02429089

Study of LEE011plus Cetuximab in Patients With a Cancer of the Head and Neck (CETLEE011)

Phase I Study of LEE011plus Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Conditions Squamous Cell Carcinoma of the Head and Neck
Interventions LEE011
Updated 9 times since 2017 Last updated: Jan 7, 2020 Started: Apr 30, 2015 Primary completion: Sep 1, 2017 Completion: Sep 1, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Decided by the investigator due to the difficulties to recruit

Other terminated trials from Cliniques universitaires Saint-Luc- Université Catholique de Louvain

See all terminations from Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Other Squamous Cell Carcinoma of the Head and Neck trials with similar outcome

Browse all Squamous Cell Carcinoma of the Head and Neck trials

A PHASE1 clinical study on Squamous Cell Carcinoma of the Head and Neck, this trial is terminated or withdrawn. The trial is conducted by Cliniques universitaires Saint-Luc- Université Catholique de Louvain and has accumulated 9 data snapshots since 2015. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~May 2018 · 16 months · monthly snapshotRecruiting~May 2018 – ~Jun 2018 · 31 days · monthly snapshotActive Not Recruiting~Jun 2018 – ~Apr 2019 · 10 months · monthly snapshotActive Not Recruiting~Apr 2019 – ~Feb 2020 · 10 months · monthly snapshotTerminated~Feb 2020 – ~Jan 2021 · 11 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotTerminated~Sep 2025 – present · 10 months · monthly snapshotTerminated

Change History

9 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated PHASE1

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated PHASE1

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE1

  4. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE1

  5. Feb 2020 — Jan 2021 [monthly]

    Terminated PHASE1

▶ Show 4 earlier versions

  1. Apr 2019 — Feb 2020 [monthly]

    Terminated PHASE1

    Status: Active Not Recruiting → Terminated

  2. Jun 2018 — Apr 2019 [monthly]

    Active Not Recruiting PHASE1

  3. May 2018 — Jun 2018 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

  4. Jan 2017 — May 2018 [monthly]

    Recruiting PHASE1

    First recorded

Apr 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Data source: Cliniques universitaires Saint-Luc- Université Catholique de Louvain

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations